Among the guideline’s recommendations is that active surveillance should serve as the preferred method of care for low-risk localized prostate cancer.
The update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.
Cancer patients taking certain immunotherapy drugs may be more susceptible to developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a recent study.
A recent study has found that genetic predictors of normal PSA levels in healthy men could be used to improve the accuracy of PSA-based prostate cancer screening.
A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Researchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.
Researchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients.
Overweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found.
“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
A new approach to prostate cancer screening has been proposed by investigators who claim the idea of informed decision-making by primary care physicians is not working when it comes to PSA testing.